Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

NCT04298853 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT04298853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04298853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
Lead sponsor
Indiana University
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2020
Completion date
October 1, 2021
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal abstinence syndrome, neonatal opioid withdrawal, neonatal opioid withdrawal syndrome